Dr. Crane is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4420 Lake Boone Trl
Ste 200
Raleigh, NC 27607Phone+1 919-784-6818Fax+1 919-784-6826
Summary
- Retired
Education & Training
- National Capital ConsortiumFellowship, Hematology and Medical Oncology, 1981 - 1984
- National Capital ConsortiumResidency, Internal Medicine, 1979 - 1981
- National Capital ConsortiumInternship, Internal Medicine, 1977 - 1978
- University of Florida College of MedicineClass of 1977
- University of Florida; Undergraduate StudiesBS, Zoology, Graduated with Honors, 1969 - 1973
Certifications & Licensure
- NC State Medical License 2021 - 2025
- MD State Medical License 1977 - 1990
- SC State Medical License 1984 - 1987
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Lifetime Achievement Award: 2017 UNC Rex Medical Staff, 2017
- Top Physician 2005-2015
- NC Hospice and Home Health Leadership Excellence Award 2015
- Join now to see all
Clinical Trials
- Single Arm on the Tolerability of Weekly Nab-paclitaxel Start of enrollment: 2013 Jun 25
- Improving Survivorship Care Through Enhanced Communication and Coordination: Pilot Study Start of enrollment: 2013 Dec 01
Publications & Presentations
PubMed
- 12 citationsNab-paclitaxel in older patients with non–small cell lung cancer who have developed disease progression after platinum-based doublet chemotherapyJared Weiss, Nathan A. Pennell, Allison M. Deal, Daniel Morgensztern, Daniel S. Bradford
Cancer. 2020-03-01 - 23 citationsUsing Survivorship Care Plans to Enhance Communication and Cancer Care Coordination: Results of a Pilot Study.Deborah K. Mayer, Allison M. Deal, Jeffrey M. Crane, Ronald C. Chen, Gary Asher
Oncology Nursing Forum. 2016-09-01 - 64 citationsA phase II study of lapatinib, a dual EGFR and HER-2 tyrosine kinase inhibitor, in patients with castration-resistant prostate cancerYoung E. Whang, Andrew J. Armstrong, W. Kimryn Rathmell, Paul A. Godley, William Y. Kim
Urologic Oncology. 2013-01-01
Committees
- Hematology MED Oncology representative, BC/BS of NC Professional and Technical Review Board 1999 - 2015
- Am Soc of Clin Oncol representative, AMA; Medical Accreditation and Quality Improvement 1998 - 2002
- Chairman, Executive Committee of Rex Healthcare 1998 - 1999
- Hematology, Medical Oncology Representative, State of NC Medicare Advisory Panel 1997 - 2001
- President, RexHealthcare Medical Staff 1997 - 1998
- Chairman, Rex Department of Internal Medicine 1995 - 1997
- President, North Carolina Oncology Society 1994 - 1996
- State of NC representative, Am Soc of Clin Oncol; Clinical Practice Committee 1992 - 2004
- Secretary and Treasurer, Rex Healthcare Executive Committee 1991 - 1993
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: